These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 12647443

  • 41. Verbal and visuospatial working memory development and deficits in children and adolescents with schizophrenia.
    White T, Schmidt M, Karatekin C.
    Early Interv Psychiatry; 2010 Nov; 4(4):305-13. PubMed ID: 20977687
    [Abstract] [Full Text] [Related]

  • 42. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
    Rémillard S, Pourcher E, Cohen H.
    Schizophr Res; 2005 Dec 01; 80(1):99-106. PubMed ID: 16162401
    [Abstract] [Full Text] [Related]

  • 43. Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.
    McKibben CE, Jenkins TA, Adams HN, Harte MK, Reynolds GP.
    Behav Brain Res; 2010 Mar 17; 208(1):132-6. PubMed ID: 19914297
    [Abstract] [Full Text] [Related]

  • 44. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
    Blin O, Fakra E, Tardieu S, Micallef J.
    Encephale; 2002 Mar 17; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
    [No Abstract] [Full Text] [Related]

  • 45. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V, Taboada D, Aragüés M, Hernández JA, Sanz-Fuentenebro J.
    Schizophr Res; 2014 Sep 17; 158(1-3):223-9. PubMed ID: 25088730
    [Abstract] [Full Text] [Related]

  • 46. The effect of risperidone on cognition in patients with schizophrenia.
    Stip E, Lussier I.
    Can J Psychiatry; 1996 Oct 17; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
    [Abstract] [Full Text] [Related]

  • 47. [Are deficits of working memory and executive functions more severe in adolescent schizophrenic patients than in adult schizophrenic patients?].
    Hintze B.
    Psychiatr Pol; 2012 Oct 17; 46(6):961-73. PubMed ID: 23479938
    [Abstract] [Full Text] [Related]

  • 48. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia.
    McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R.
    Schizophr Res; 2004 Jun 01; 68(2-3):225-33. PubMed ID: 15099605
    [Abstract] [Full Text] [Related]

  • 49. Risperidone treatment of schizophrenia: improvement in psychopathology and neuropsychological tests.
    Borkowska A, Araszkiewicz A, Rajewski A, Rybakowski JK.
    Neuropsychobiology; 2002 Jun 01; 46(2):85-9. PubMed ID: 12378125
    [Abstract] [Full Text] [Related]

  • 50. Guanfacine treatment of cognitive impairment in schizophrenia.
    Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL.
    Neuropsychopharmacology; 2001 Sep 01; 25(3):402-9. PubMed ID: 11522468
    [Abstract] [Full Text] [Related]

  • 51. [The new antipsychotic preparation Rispolept (risperidone)].
    Iakovlev VA.
    Voen Med Zh; 1999 Nov 01; 320(11):43-5. PubMed ID: 10650767
    [No Abstract] [Full Text] [Related]

  • 52. Symptoms of schizophrenia and neurocognitive test performance.
    Shean G, Burnett T, Eckman FS.
    J Clin Psychol; 2002 Jul 01; 58(7):723-31. PubMed ID: 12205713
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, Macewan GW, Lang DJ.
    Schizophr Res; 2013 Sep 01; 149(1-3):149-55. PubMed ID: 23830856
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
    Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J.
    Am J Psychiatry; 1997 Jun 01; 154(6):799-804. PubMed ID: 9167507
    [Abstract] [Full Text] [Related]

  • 57. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.
    Lane CJ, Ngan ET, Yatham LN, Ruth TJ, Liddle PF.
    J Psychiatry Neurosci; 2004 Jan 01; 29(1):30-7. PubMed ID: 14719048
    [Abstract] [Full Text] [Related]

  • 58. Saccadic hypometria in drug-naive and drug-treated schizophrenic patients: a working memory deficit?
    Hutton SB, Cuthbert I, Crawford TJ, Kennard C, Barnes TR, Joyce EM.
    Psychophysiology; 2001 Jan 01; 38(1):125-32. PubMed ID: 11321613
    [Abstract] [Full Text] [Related]

  • 59. Comparison of risperidone and other neuroleptics in the management of chronic schizophrenia using cognitive therapy.
    Azhar MZ.
    Med J Malaysia; 2000 Mar 01; 55(1):7-13. PubMed ID: 11072484
    [Abstract] [Full Text] [Related]

  • 60. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr 01; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.